Impact on prognosis of lymph node micrometastasis and isolated tumor cells in stage II colorectal cancer

Journal of the Korean Society of Coloproctology

Volumn 27, Issue 2, 2011, Pages 71-77

  Oh, Tai Young ^a   Moon, Sun Mi ^a   Shin, Ui Sup ^a   Lee, Hyang Ran ^a   Park, Sun Hoo ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

Colorectal neoplasm; Isolated tumor cells; Lymph node; Micrometastases; Ratio

Indexed keywords

CYTOKERATIN ANTIBODY;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOLATED TUMOR CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; SURVIVAL RATE; TUMOR CELL;

EID: 84855522307     PISSN: 20937822     EISSN: 20937830     Source Type: Journal    
DOI: 10.3393/jksc.2011.27.2.71     Document Type: Article

References (26)

1. National Cancer Center. Cancer incidence in Korea 1999-2001. Goyang: National Cancer Center; 2005.
2. Edge, Stephen B. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
3. Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698-702.
4. Choi HJ, Jung IK, Kim SS, Hong SH. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas. Dis Colon Rectum 1997;40:51-9.
5. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
6. Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996;162:637-42.
7. Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum 1997;40:1465-71.
8. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 2006;244:602-10.
9. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-8.
10. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417-20.
11. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 2003;98:2740-1.
12. Huvos AG, Hutter RV, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173:44-6.
13. Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ. Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 2007;9:563-71.
14. Noura S, Yamamoto H, Ohnishi T, Masuda N, Matsumoto T, Takayama O, et al. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 2002;20:4232-41.
15. Bilchik AJ, Hoon DS, Saha S, Turner RR, Wiese D, DiNome M, et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg 2007;246:568-75.
16. Park SJ, Lee KY, Kim SY. Clinical significance of lymph node micrometastasis in stage I and II colon cancer. Cancer Res Treat 2008;40:75-80.
17. Lee MR, Hong CW, Yoon SN, Lim SB, Park KJ, Lee MJ, et al. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer. J Surg Oncol 2006;93:13-8.
18. Bosch Roig CE, Rosello-Sastre E, Alonso Hernandez S, Almenar Cubells D, Grau Cardona E, Camarasa Lillo N, et al. Prognostic value of the detection of lymph node micrometastases in colon cancer. Clin Transi Oncol 2008;10:572-8.
19. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 2001;8:300-4.
20. Verrill C, Carr NJ, Wilkinson-Smith E, Seel EH. Histopathological assessment of lymph nodes in colorectal carcinoma: does triple levelling detect significantly more metastases? J Clin Pathol 2004;57:1165-7.
21. Sasaki M, Watanabe H, Jass JR, Ajioka Y, Kobayashi M, Matsuda K, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer. J Gastroenterol 1997;32:758-64.
22. Brown HG, Luckasevic TM, Medich DS, Celebrezze JP, Jones SM. Efficacy of manual dissection of lymph nodes in colon cancer resections. Mod Pathol 2004;17:402-6.
23. Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, Perez de Arenaza D, et al. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum 2009;52:1244-50.
24. Noura S, Ohue M, Kano S, Shingai T, Yamada T, Miyashiro I, et al. Impact of metastatic lymph node ratio in node-positive colorectal cancer. World J Gastrointest Surg 2010;2:70-7.
25. Telian SH, Bilchik AJ. Significance of the lymph node ratio in stage III colon cancer. Ann Surg Oncol 2008;15:1557-8.
26. Wang J, Hassett JM, Dayton MT, Kulaylat MN. Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol 2008;15:1600-8.